263 related articles for article (PubMed ID: 9990606)
1. The long QT syndrome and torsade de pointes.
el-Sherif N; Turitto G
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):91-110. PubMed ID: 9990606
[TBL] [Abstract][Full Text] [Related]
2. Torsade de pointes.
El-Sherif N; Turitto G
Curr Opin Cardiol; 2003 Jan; 18(1):6-13. PubMed ID: 12496496
[TBL] [Abstract][Full Text] [Related]
3. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
Shimizu W; Antzelevitch C
J Electrocardiol; 1999; 32 Suppl():177-84. PubMed ID: 10688323
[TBL] [Abstract][Full Text] [Related]
4. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
Antzelevitch C; Yan GX; Shimizu W
J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns.
El-Sherif N; Chinushi M; Caref EB; Restivo M
Circulation; 1997 Dec; 96(12):4392-9. PubMed ID: 9416909
[TBL] [Abstract][Full Text] [Related]
6. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Shimizu W; Antzelevitch C
Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
[TBL] [Abstract][Full Text] [Related]
7. Acquired long QT syndrome and torsade de pointes.
El-Sherif N; Turitto G; Boutjdir M
Pacing Clin Electrophysiol; 2018 Apr; 41(4):414-421. PubMed ID: 29405316
[TBL] [Abstract][Full Text] [Related]
8. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
9. Congenital Long QT syndrome and torsade de pointes.
El-Sherif N; Turitto G; Boutjdir M
Ann Noninvasive Electrocardiol; 2017 Nov; 22(6):. PubMed ID: 28670758
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and Management of Athletes With Long QT Syndrome.
Gomez AT; Prutkin JM; Rao AL
Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
[TBL] [Abstract][Full Text] [Related]
11. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
Kirchhof P; Franz MR; Bardai A; Wilde AM
J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
[TBL] [Abstract][Full Text] [Related]
12. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
13. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
Shimizu W; McMahon B; Antzelevitch C
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of ventricular arrhythmias in the long QT syndrome: on hermeneutics.
El-Sherif N
J Cardiovasc Electrophysiol; 2001 Aug; 12(8):973-6. PubMed ID: 11513452
[TBL] [Abstract][Full Text] [Related]
15. Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome.
Akar FG; Yan GX; Antzelevitch C; Rosenbaum DS
Circulation; 2002 Mar; 105(10):1247-53. PubMed ID: 11889021
[TBL] [Abstract][Full Text] [Related]
16. Cycle length-associated modulation of the regional dispersion of ventricular repolarization in a canine model of long QT syndrome.
Chinushi M; Caref EB; Restivo M; Noll G; Aizawa Y; El-Sherif N
Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1247-57. PubMed ID: 11523611
[TBL] [Abstract][Full Text] [Related]
17. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
Shimizu W; Antzelevitch C
Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of pause-induced torsade de pointes in long QT syndrome.
Liu J; Laurita KR
J Cardiovasc Electrophysiol; 2005 Sep; 16(9):981-7. PubMed ID: 16174020
[TBL] [Abstract][Full Text] [Related]
19. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of sudden death in congenital long-QT syndrome].
Oliveira M; Antunes E; da Silva MN
Rev Port Cardiol; 1999 Jun; 18(6):627-33. PubMed ID: 10422460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
